The purpose of this study was to demonstrate that dynamic MRI covering both breasts can provide sensitivity for tumor detection as well as specificity and sensitivity for differentiation of tumor malignancy. Three-dimensional gradient echo scans were used covering both breasts. Before Gd-DTPA bolus injection, two scans were obtained with different flip angles, and after injection, a dynamic series followed. Thirty-two patients were scanned according to this protocol. From these scans, in addition to enhancement, the value of Tl before injection was obtained. This was used to estimate the concentration of Gd-DTPA as well as the pharmacokinetic parameters governing its time course. Signal enhancement in three-dimensional dynamic scanning was shown to be a sensitive basis for detection of tumors. In our series, all but two mammographically snspicious lesions did enhance, and in three cases, additional enhancing lesions were found, two of which were in the contralateral breast. The parameter most suited for classification of breast lesions into benign or malignant was shown to be the pharmacokinetically defined permeability kl, which, for that test, gave a sensitivity of 92% and a specificity of 70%. Our three-dimensional dynamic MRI data are sensitive for detection of mammographically occult breast tumors and specific for classification of these as benign or malignant. Abbreviations: DClS = ductal carcinoma in situ, FFE = fast field echo, fom = figure of merit. Gd-DTPA = gadolinium diethylenetriamine penlaacetic acid. NSA = number of signals averaged, ROC = receiver operating characteristic, R01 = region of interest.
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DIAGNOSIS OF BREAST LESION malignancy usually is based on core biopsy guided by x-ray mammography or ultrasound. However, there are classes of patients for whom such a method is not optimal. This, for example, is the case when a lesion is small, multifocal, or not well delineated. In such cases, surgical biopsy would be needed. For reduction of patient morbidity and financial expense, it would be desirable to avoid unnecessary biopsies by a noninvasive test that is sensitive for lesion detection as well as specific for distinction between benign and malignant. Additionally, such a test could be of value for follow-up studies of breast lesions after lumpectomy or chemotherapy.
Contrast-enhanced MRI may be suitable for these purposes . Rapid enhancement of the signal in postcontrast images is strongly indicative of the presence of a lesion. This can be observed when the scan is repeated as a dynamic series (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (14) (15) (16) (19) (20) (21) (22) (23) (24) . However, thereported specificity for classification of breast lesions as benign or malignant is not always satisfactory (5, 7, (10) (11) (12) .
In some of the quoted literature (11) (12) (13) (14) (15) (16) 21) , the scan methods are aimed at the detection of contrast enhancement in the complete breast. The scans used by Heywang et a1 (111, Harms et al (121, and Perman et al (15) cover one entire breast; those of Rigauts (13) cover both breasts. In these cases, the MRI examination can be used for detection of occult lesions. Sensitivity of the MRI examination in this respect is shown to be important because of the potential presence of lesion multifocality (12) or when lesion location is uncertain (13, 15) . At high spatial resolution of 1 x 1 x 5 mm3 Ill) or 1 x 1 x 1 mm3 (12), lesion detection sensitivity is found to be close to 100% for cases that already are suspected on the basis of x-ray mammography. However, in these last reports, the temporal resolution was low (300 seconds per scan) and differentiation between benign and malignant was not adequately possible.
In studies by Perman et a1 (15) and Hulka et al (21) , an approach is presented in which enhancement is inspected dynamically with a much higher temporal resolution, 44 seconds (15) and 6 seconds (211, while the entire breast is covered at the same time. Such an approach is attractive when detection sensitivity as well as specificity for tumor classification are both required. To reach sufficient temporal resolution, in these reports, a three-dimensional scan technique was used with a moderate spatial resolution (pixel size is 3 x 1 x 2 mm3 in one breast (1 5) and 7 X 1.5 X 3 mm3 in both breasts (2 1)). In the present study, this approach is used as well and our scan is a dynamic scan that covers both breasts with a temporal resolution of 30 seconds and spatial resolution of 6 X 1.3 X 1.7 mm3.
A more advanced data analysis is possible (16-24) when the enhancement-time courses are converted to concentration-time courses, using the precontrast relaxation time T1 (in this report called the native Tl). In such an approach, the enhancement is replaced by the contrast medium concentration, thereby removing the influence of this tissue property from the data. In the present study, accordingly, the native T1 is determined for each patient and each enhancement factor is reduced to gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) concentration.
In addition, in the same reports, the shape of the concentration-time course is modeled as a pharmacokinetic curve. In these models, the leakage of the contrast agent into the interstitial space is seen as the cause of the signal enhancement. Hulka et a1 (21) demonstrated statistically that the derived pharmacokinetic parameter, when compared with signal enhancement, improves the degree of separation between malignant and benign breast lesions, but they do not show whether this improvement is due to their correction for T1 or to their pharmacokinetic modeling. To inspect the potential of this approach, we have fitted the dynamic T1 corrected MR data to a pharmacokinetic model, derived from that ofTofts et a1 (20, 22) and obtained model parameters.
The purpose of our work is to determine the sensitivity for tumor detection obtained with our three-dimensional dynamic contrast-enhanced MRI scan, given its moderate spatial resolution. Next, we want to find the sensitivity and specificity for classification of lesions as benign or malignant that can be reached with our data and the contribution of each of the two steps that we have taken in data reduction: correction of the enhancement data for native T1 and pharmacokinetic curve fitting.
MATERLALS AND METHODS

Patients
Thirty-two patients participated in the study on a voluntary basis. These patients were chosen when mammographic images gave reason to suspect a malignancy, and for each patient, the decision already had been made that biopsy was needed. The first group of 15 patients (age range, 50-70 years; mean age, 57 years) consisted of clients from the Dutch mass population screening. In this group, only women who had nonpalpable lesions were included. The second group of 17 patients (age range, 30-80 years: mean age, 53 years) consisted of symptomatic patients who presented without previous breast tumor treatment and for whom surgical biopsy was planned. The study protocol was accepted by the Ethical Committee of our institution. The MFU examination always was carried out before biopsy, However, this result was not permitted to influence the course of the patients' treatment.
X-Ray Mammography and Histology
All x-ray examinations were performed with a Senograph 600 I mammography system (CGR, Paris, France), using craniocaudal, oblique, and mediolateral views. A biopsy was obtained from all mammographically suspicious lesions. Biopsy locations were guided by the x-ray mammographic results. In all cases, the specimen was removed surgically. After its entire surface had been inked to facilitate microscopic recognition of the surgical edges, it was sectioned at 5-mm intervals and of each part an x-ray image was taken. These images were used during the surgical procedure to confirm that the suspected tissue was contained in the specimen. Tissue blocks for paraffin microscopy sections were then obtained of all grossly and mammographically suspicious areas.
MRI
MR images were obtained with a Gyroscan ACS MRI system (Philips Medical Systems, Eindhoven, the Netherlands) operating at 1.5 T. The patients were positioned prone with both breasts placed in a recess in a linear receive-only surface coil. The coil design restricted motion of the breast tissue in the craniocaudal direction. After a preliminary scan for localization, all scans were made in the axial direction with a field of view of 320 mm. For all scans, a spoiled gradient echo method, Tl-enhanced fast field echo (Tl-FFE), and three-dimensional encoding were used. For each scan, 36 partitions of 6 mm thick and 3-mm overlap (Fourier interpolation) were obtained. In this way, the scanned volume had a thickness of 108 mm and covered all space in the coil recess. The phase-encode gradient was left to right, so that the movement artefact of the heart did not cross the breasts, except for the extreme axillary regions. The scan parameters of the first of the T1-FFE scans were as follows: TR/ TE = 16/9 msec, flip angle = 4", acquisition matrix nz X ny X nx = 18 X 192 X 256; number of signals averaged (NSA) = 2. The value of TE was the lowest in-phase value obtainable in our system. This scan was made to allow calculation of the native relaxation time T1 (see Appendix B). The subsequent seven scans were a dynamic series with the same scan parameters, except for the flip angle (40") and NSA (1) . In the dynamic series, the duration of each scan was 30 seconds, which was the minimum that could be achieved with the number of slices and the matrix size. A half scan technique and an elliptic coverage of the k plane' were used for scan time reduction. The half scan technique was used in the k, direction. Within each scan, the k, and k, values were changed in linear order in a nested loop with the k, values varying in the inner loop. This caused the moment at which both k, and k, were zero to occur at a time halfway through each scan. That moment, 15 seconds after the start of each scan, is the one that best characterizes the dynamic situation that is described in the image. We will call this moment the characteristic time tc of the scan.
Before the start of the scans, an injection needle was inserted in the cubital vein in the right antecubital fossa.
A syringe with 7.5 mmol of Gd-DTPA (Magnevist; Schering, Berlin, Germany; 15 mll was connected with the needle via a 15-ml cannula filled with physiologic saline, This setup allowed injection during the dynamic series without movement of the patient.
The start times of the dynamic scans were ts = 0, 50, 80, 140, 210, 280, and 350 seconds. Completion of the first scan was the sign for the radiologist to start injection. The syringe was emptied into the cannula in approximately 5 seconds, and the tube was then flushed with 25 ml of saline in another 5 seconds. Therefore, a bolus of contrast medium entered the body starting at 5 seconds after thr end of the first dynamic scan. The transport time tt of the contrast medium from the site of injection to the breast was estimated to be 15 seconds. This equals the mean delay to peak of the digital subtraction angiography signal a s observed in the carotids in intravenously-injected iodine contrast studies (25) (for discussion of the error in this estimate, see Appendix D). As a result, the nominal arrival time of the bolus coincided with the start time of the second dynamic scan (ts = 50 seconds). This time was taken as the zero point of the pharmacokinetic time scale. On this scale, the characteristic times of the remainder scans were at:
Lesion Detection
For lesion detection, the two three-dimensional sets of preinjection images (small and large flip angle) were presented to the radiologist, along with subtraction images that were made from the first and the second postinjection scan, using the preinjection scan of the dynamic series as a mask. Detection of lesions was based on visual inspection of these MR images and correlation of the findings to x-ray mammography. All mammographic suspicious lesions could be found confidently by visual inspection of the images. All slices with visually apparent lesions were subjected to numeric analysis.
The numeric analysis of the MRI data was performed on a workstation on each of the slices selected by the radiologist. To correct for motion of the patient between the scans, when necessary, the images (eight images of each slice) were registered with the help of a two-dimensional shift tool. Shifts were possible in steps as small as . 1 times the pixel size. The tool required operator supervision to select the most satisfactory shift. Although subjective, the process was reproducible within .3 pixels, as tested by comparing the shift obtained by two different observers.
Objective and automatic definition of enhancing regions was based on comparison of the actual enhancement-time course of each pixel to a typical reference course. To do so, the images of the dynamic scan were reduced to a single weighted sum image. The technique used for this reduction is derived from eigen image filtering (26) and discussed in Appendix A. The reference enhancement values are listed in Table A l . In the weighted sum image, the pixel values are high when there is a close match between the actual and the reference enhancement-time course. To define the enhancing region, the weighted sum image was thresholded at 75% of its m aimum pixel value. When no supra threshold region resulted, the threshold was reduced to 50 Yo and, if necessary, to 30%. Regions smaller than 8 connected pixels were rejected to avoid misreadings from data that were strongly distorted by partial volume effects.
The sensitivity of detection of the lesions by enhancement was obtained by comparing the generated enhancing regions with the visually ascertained lesions. Moreover, the enhancing regions were used to define mean values for each of the parameters derived per pixel.
In a few cases with very low enhancement, no enhancing region showed up in the automated procedure. Then, the lesion was considered to be nonenhancing and, for evaluation of mean parameter values, a region of interest (ROI) corresponding to the visual area of the lesion was defined manually.
Parameters Obtained per Piwe1
From the ratio of the two precontrast scans, the relaxation time of the native tissue (Tl,) was calculated with help of Equations [Bl] and [BZ] in Appendix B. The scans had a constant scale so that all signal values for each pixel were directly physically comparable. For each pixel, the ratios of the postcontrast and precontrast scans of the dynamic series defined six enhancement factors. With Equations [Bll and IB31, the Gd-DTPA concentrations per pixel could be derived from these enhancement factors and Tl,. The enhancement factor observed for the third dynamic scan [at t = 45 seconds) and the corresponding concentration were recorded for later use and were called Enh (45) and Gd(451.
A pharmacokinetic model similar to that of Tofts et a1 (22) was used to describe the time course of the contrast medium concentration. The model and its assumptions are discussed in Appendix C. Three parameters are obtained: A, the fractional volume of the vascular space; &, that of the leakage space: and k,,, the permeability of the boundary between plasma and leakage space.
The modeled signal enhancement was fitted to the data by adjustment of these parameters. This was based on minimization of the squared differences between the modeled and the observed enhancement factors (Levenberg Marquardt method). The mean value of the residual squared differences, normalized to image noise (see Table   Dl ), was used as a figure of merit (fom) for the fit.
Statistical Analysis
Per enhancing region, a mean value was obtained for each of the parameters, Tl, , Enh[45) , Gd(45) , fL, h, and kl, by averaging over all pixels in that region. When more than one enhancing region was present in one lesion (the lesion was, for example, seen in more than one slice), all enhancing regions were analyzed. The parameter values belonging to the region with the highest mean were used to describe the lesion. Statistical significances of these MRI-based lesion parameters were obtained by comparing histology. For some of the parameters, receiver operating characteristic (ROC) curves and scatter diagrams were used to inspect their suitability for lesion classification. Figure 1 shows some of the images obtained for a patient with a large phyllodes tumor (case 4). Details describing how these images were reached are given in the legend of this figure. The signal-to-noise ratio in the original MR images (Figs. la, lb, and lc) is approximately 2% of the unenhanced glandular signal. The area of enhancement at 45 seconds ( Fig. lc) is rather homogeneous and its visual contour has a fair correspondence to that selected by our automatic procedure (Figs. lf, lg, and lh). best fitting pharmacokinetic model-based enhancementtime curve is drawn for comparison. Two benign cases are shown in Figure 2a and two malignant cases are shown in Figure 2b . The model parameters and the fom for the fit of these curves are given in the figure caption. All curves in this figure fit within the error ranges, illustrating that our model did give an adequate description of the data. The mean fom for all fits (each pixel in the enhancing region, all patients) is 2.6. Table 1 lists the demographic, mammographic, histologic, and MRI data for each patient. All MRI parameters are mean values over one enhancing region per lesion (the one for which highest mean $, was found). The fraction of the tumor volume covered by this region was estimated to range from approximately 5% for large tumors to more than 50% for small tumors. All data for mammographically nonsuspicious lesions (no histology available) are printed in italics. The cases are arranged in order of histologic class and within each class in order of increasing
RESULTS
In cases 5 and 8, the lesions did not visibly enhance in MRI. These lesions could be included for analysis after identification on basis of their conspicuity in the precontrast images. In case 18, the lesion was situated in the axillary region of the breast and part of it was in an area that was heavily corrupted because of flow artefacts emanating from the heart. In this case, the analysis was carried out on a manually defined ROI outside the artefact zone. One or more enhancing regions were found in 32 of 34 lesions, so that the sensitivity for tumor detection on basis of enhancement was 96%.
Data from Table 1 are summarized in Table 2 (lesions for which histology was available), which shows means (h] Parameter map of permeability kZ1 (gray scale: kal = 0...100.10-3 sec-I).
and SDs of T I , Enh(45) , Gd(451, fi, f,, and k& taken from Table 1 for the groups of benign and malignant cases. For comparison, corresponding values are shown for normal fat and normal glandular breast tissue. These were obtained from data of a group of seven normal breasts. Of particular interest are the differences of the parameter values between benign and malignant lesions. The statistical significance of these differences was tested with the Wilcoxon rank sum test and is given per parameter. Compared with benign lesions, malignant lesions had a significantly larger mean value of Gd (45), Jl, and kdl. Of these, the difference in k1 has the highest significance (P < .005), followed by that infi (P < .02).
In Figure 3 , the observed values of Enh (45) Figure 4 shows ROC curves belonging to tests of tumor malignancy with some of the derived lesion parameters. In each curve, the true-positive rate is plotted against the false-positive rate with the threshold for testing as parameter and histology as gold standard. Shown are curves for Enh (4.51, Gd(45) , and hl. The ROC curve for b1
shows the largest true-positive rates, followed by the curve for Gd (45) . Figure 5 shows scatter diagrams in which the lesion parameters used in Figure 4 are compared with histologic diagnosis. In these diagrams, for purpose of illustration, malignant in situ and malignant invasive lesions are presented as separate classes. Suggested threshold values are added to show the results of a tumor malignancy test based on each of the diagrams. Using for k,, a threshold of 14 * lo-" sec-I, there are three false positives and two false negatives, so that for this combination of test parameter and threshold, the sensitivity for classification of malignant tumors is 92% and the specificity is 70%.
Inspection of the individual false cases in Table 1 shows that one of the false-positive cases is a fibroadenoma and the other two are adenosis and adiponecrosis, both characterized by a low TI and a low enhancement factor. The false-negative cases both were comedo-type ductal carcinomas in situ. Figure 5 suggests that the average of ductal carcinoma in situ (DCIS) tumors may be different from that of invasive tumors, but the difference found was not significant. Finally, Table 3 shows an overview of enhancing regons that did not correlate to mammographically detected lesions. In case 10, follow-up x-ray mammography 1 year after lumpectomy of the left breast did not show suspicious abnormalities in either breast. In case 11, both breasts were resected. In case 27, follow-up x-ray mammography 1 year later did not reveal a n abnormality in the contralateral (right] breast.
DISCUSSION
Quantitative Diagnosis
From the MR images, we extracted numeric data on signal enhancement and used these for diagnostic purpose. Such a quantitative diagnosis must be objectively based. To show how we achieved this, we have @ven a detailed account of the steps used in the data analysis. Arbitrary choices sometimes had to be made and these can influence the parameter values obtained. In this respect, the representation of the lesions by enhancing regions is important. The enhancing regions were selected by an objective criterion in the fastest enhancing part of the lesion. Because of lesion heterogeneity, the enhancing regions found in some patients were much smaller than the (visually apparent) lesion size. This is in line with a remark of Boetes et a1 (181, who discuss occasional large differences in size between the enhancing region and the lesion.
In the process of reduction of the data to a single diagnostic descriptor per lesion, the representativeness of this descriptor should not be lost. Is the enhancingregion representative for the lesion as a whole? Gribbestad et a1 (19) argue that restriction to the maximally enhancing region is necessary for a specific diagnosis. We approximated this requirement by our definition of the enhancing regions and by our choice of reporting the parameter values of one enhancing region only. The representativeness of this choice is supported by the observation that the parameter values found for different enhancing regions belongmg to the same lesion usually were similar.
Moreover, quantitative diagnostic information must be obtained with a sufficiently small measurement error. The enhancement factors per pixel have a n accuracy about equal to the MR image noise (2%). The concentrations of Gd-DTPA are less accurate because of the error in calculation of T1, (15%) (see Appendix D). An assess- The fom of the fit in most of these figures is lower betier) than that of most fits per pixel, because of noise reduction by averaging the enhancement values over the HOI. Note that the parameters for fit given in the figure captions are not the same as those in Table 1 . The difference arises because in this figure the fit is to the average of the enhancement factors per ROI, whereas in Table 1 Table D1 and Table 2 shows that, for lesions, the observed distribution infi and& can be explained by measurement errors, but even per group of lesions, the distribution in T1 and Is, is significantly larger than the measurement error.
The relatively high accuracy of k,, (20%) was reached because there was only little propagation to this parameter of the errors in V, and tt [illustrated in Figure C2 ). V, relates to the ordinate scale and tt relates to its offset.
Where fi and f, are influenced by the ordinate scale and its offset, Isl is a measure only of the curvature of the enhancement-time curves.
As a consequence, in our model, relatively accurate b1
values can be obtained without knowledge of the bolus arrival time per patient. Accuracy of kS1 will be preserved as long as its value is smaller than ]/At, the inverse of the time between the dynamic scans, For At = 30 seconds, this corresponds to Is1 < 33 * sec-I. In our series, the mean b, for benign lesions was 15-10-3 sec-' and for malignant lesions 35 X lo-, sec (see Table 2 ).
The argument shows that the temporal resolution used in our dynamic scan was sufficient to resolve in the range of interest.
Tumor Detection
A first important aspect of our results is that enhancement, as found in our data, is a reliable detection criterion for mammographically suspicious lesions with a detection sensitivity of 96%. This high sensitivity is relevant for detection of lesions not found before the MRI examination. Table 3 shows that in our series of three patients (10% of the cases) eight enhancing regions were found that were not suspicious in x-ray mammography. These new findings suggest the presence of additional lesions, although no histologic proof of their presence was obtained. (At the time of this study, MRI-guided biopsy support tools were not available.] Two of the patients with new findings entered through the population screening program. Moreover, two of the new findings were in the contralateral breast.
We used a n axial slice orientation, which precluded inspection of the extreme axillary regions of the breasts because in these areas the images frequently were damaged by motion artefacts emanating from the beating heart. As a n alternative, we could have used a sagittal scan (as was done in refs. 11, 12, and 15), more completely covering a single breast and at the same time allowing a smaller field of view and, therefore, a higher spatial resolution. Such changes in the scan technique potentially could have revealed smaller and more additional breast lesions but at the cost of loosing the coverage of both breasts.
The minimum lesion size detectable by our data analysis method equals the minimum size of the enhancing regions below which they are rejected. This size was 8 pixels, corresponding to a detection limit of about 6 X 6 x 6 mm3. Scans with higher spatial resolution covering both breasts also would have been possible, but only at a lower temporal resolution of the dynamic scan. However, as discussed above, the temporal resolution used in our work is needed to allow assessment of the malignancy of the breast lesions. Harms and Flamig (12) concluded that 36% of malignant lesions detected with MRI were not found by x-ray mammography. This percentage of cases with new findings is higher than we found in our series. The reason may be related to the smaller voxel used in their study (1 X 1 X 1 mm3), which is likely to correspond to a smaller detection limit, but in the cited study, the specificity for tumor classification was low.
Tumor Classification
The KOC curves of Figure 4 and the scatter diagrams of Figure 5 compare the degree of separation of malignant and benign lesions that can be obtained from the data. Testing of the lesions on Enh(45) is similar to the tests on Volume 7 Number 4 JMRl 707 fast enhancement used frequently in the earlier literature (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Inspection of the ROC curve for this parameter and of the corresponding scatter diagram in Figure 4a shows that for our data this approach is not very successful.
A first cause of the relative lack of specificity in testing to Enh(45) is illustrated in Figure B1 , which shows from theory that this parameter depends on Tl,. This was pointed out already by Tofts et a1 (20) and Hulka et a1 (21) . Experimental confirmation of this dependence as a strong correlation between these quantities is shown in Figure 3a .
Improved separation can be expected when the data are corrected for T1, This correction is obtained by conversion of enhancement into Gd-DTPA concentration. The improvement reached is illustrated by the ROC curve for Gd(45) in Figure 4 and in the scatter diagram of Figure 5b .
as a test criterion is suggested by Tofts et a1 (20) and by Hulka et a1 (21) , who used for the same parameter the term "extraction flow product" (EF). Figure  3b shows that has the required independence of T1,. The ROC curve in Figure 4 for testing to and the scatter diagram in Figure 5c show indeed a further improvement above that based on M(45).
The use of
708 JMRl July/August 1997 I The areas under the ROC curves in Figure 4 were compared statistically in a paired test (2729) and were shown to be not significantly different. However, on this scalp, the difference between k . , and enhancement was almost significant (P = .91).
As a result, k,, is shown to be a powerful test criterion for tumor classification. Conditional for the power of the test is that a sufficient accuracy is obtained for this parameter. In our method, as discussed above, such an accuracy could be obtained without observation of the bolus arrival time and with a dynamic scan with a temporal resolution of 30 seconds.
Pharmacokinetic analysis of the data should allow a direct comparison to the results of other groups obtained with similar methods. One of these groups is H u k a et al (21) , but from their paper, one can derive that in their patients, the mean value of EF for benign lesions is 3 -sec-I and for malignant lesions 8 . 10 sec This is much lower than the values shown in Table 1 for (14 and 35 * 10 ., respectively). This difference is surprising and may be related to a difference in definition of the enhancing regions. Hulka et a1 used a threshold for EF of 6 -10-J sec-I. When their threshold is used in Figure 5c, no false negatives and five false positives result, so that this threshold could be defended as suitable for our data (we suggest a threshold of 14 -lo-. sec I).
Hulka et a1 used a scan method with a very high temporal resolution (6 seconds). Even with their modern echo planar scan technique, this was cause for a rather coarse spatial resolution (pixel size of 7 X 1.5 X 3 rnm-.]. For tumor classification, they noted for their test a sensitivity of 86% and a specificity of 93%. When testing with k1 we found a similar sensitivity of 92% and a somewhat lower specificity of 70%. The difference between the test results may be caused by poor statistics because of the small series used (Hulka et al: 20 patients; our series: 32 patients).
Considering the obtained test results, the relatively low temporal resolution of our scan method seems to be compatible with a high specificity for tumor classification. This means that there is opportunity for a scan with a high spatial resolution. In our system, we reached a spatial resolution of 6 X 1.3 X 1.7 mm3. Increased system specifications would be desirable in the first place to further improve this spatial resolution. Based on gradientecho techniques, such improvement could be reached with stronger gradients allowing a short (in-phase) TE of 4.5 msec and a short TR. Echo-planar techniques could bring a moderate fiirther improvement in resolution, although determination of T1 by our dual flip angle method would not be possible.
Interpretation of Obtained Parameters
The pharmacokinetic parameter values found for normal tissue and lesions, as shown in Table 2 , can be interpreted, to some extent, as properties of the tissue. This is because these parameters have a biophysics definition and are independent of the MR technique used. The volume fractionsf, andf, of the vascular and leakage space compartment in the voxel as defined in the model and given in Table 2 can be compared with other data. In normal peripheral tissue, the capillary space is 1% (30,31) , and in adult females, the extracellular water content is 20% (32). These values are not unlike our values offi and f, of normal glandular tissue and fat.
The values off, in benign as well as malignant lesions are higher than those of normal tissue, as shown in Table 2 .
This may be related to tumor-associated angiogenesis instance, Boetes et al (18) ascribe the onset of their enhancement-time curves as an arterial contribution to the signal. Gilles et al (9) and Hulka et al(21) find a correlation between increased capillary density and tumor enhance- (33) show the presence of localized areas of dense and permeable capillaries in the tumor in their study of MCF-7 human breast tumors implanted in nude mice. In addition, they show the enhancement of such areas in dynamic MRI after Gd-DTPA injection. Shweiki et a1 (34) conclude that leakage and angiogenesis may occur simultaneously in malignant human tumor tissue. Table 2 shows that the values off, found in lesions are large a s well. The combined occurrence of the elevated values off, and f, can explain the high detection sensitivity of contrast-enhanced MRI both for benign and malignant breast lesions.
In conclusion, our data support the notion that malignant breast tumors are characterized by neovascularization and vessel leakage. However, we have no statistical evidence regarding whether such properties will depend on the histologic type of the tumors that were found in our series, nor can we predict the pharmacokinetic behavior of still other types of breast tumors. Neovascularization in malignant tumors could be specifically dependent onfi andf,. Our measurement accuracy was not sufficient to resolve such a dependence. Table 1 In our tumor classification tests, one of the false positives was the same case of fibroadenoma (case lo), which is characterized by a high kS1. Apparently, even after our data reduction, fibroadenomas can mimic malignant tumors and can be expected to create false positives in future tests. The false negatives usually included comedo-type ductal carcinoma in situ, of which Gilles et al (9) note that angiogenesis sometimes is weak. Figure 5 suggests that permeability in these tumors may be weak as well. Future tests may have false-negative findings for such lesions. These remarks indicate that MRI based noninvasive testing of breast lesions does not obviate the need for histology.
CONCLUSIONS
This study shows that our method of scanning, with its moderate spatial resolution and moderate temporal resolution, allowed a sensitive detection of tumors in a region covering both breasts as well a s a sensitive and specific classification to malignancy of the tumors detected. The accuracy of classification was shown to be improved by removal of the influence of the native T1 from the data as well as by subsequent phannacokinetic modeling. The pharmacokinetic permeability could be found with a n acceptable measurement accuracy (20%).
Based on enhancement, the lesion detection sensitivity was 96%. Classification of tumors with was possible with a sensitivity of 92% and a specificity of 70%. The potential value of the proposed method for detection of new malignant tumors not suspicious in x-ray mammography was illustrated by the findings in three patients of six new enhancing regions. Five of these had a value of
The small number of patients tested in this study limits its prognostic value. Additional tests are needed to prove the clinical value of our approach. Improvement of measurement accuracy may be needed to find equal or better specificity in future series. Such improvements can be realized. However, the test accuracy obtained in our study already indicates that the clinical value of our method for patients or clients of population screening with unclear diagnosis or with high risk factors may exist.
indicating malignant behavior.
a MPENDIXA
Derivation of the Weighted Sum Image
In the dynamic contrast injection studies, contrast enhancement is observable in a number of scans. To em- Table 2 ) and smoothing these data. d and u create the weighting factors (vector e J for the weighted summation of the enhanced images that maximizes the contrast-tonoise ratio between the desired and the undesired tissue property vectors.
The elements of the vector e are listed in Table Al 
DTPA
For the T1-FFE imaging method, the spoiled gradientecho sequence available on our system, the signal strength s is shown theoretically and experimentally verified by Van der Meulen et al (35) to be given by: is caused by the tissue concentration of Gd-DTPA. Equation [B3] is the experimental result taken from Weinmann et al (37) and holds over the range of Gd-DTPA concentrations occumng in clinical practice: 0 to 2 mmol/l:
_ -
with r, and r, * the relaxivities (1 mmol-I sec-') and C, the average value of concentration of the contrast medium taken over all tissue in the voxel (mmol 1 I). When the dynamic series starts with a scan before arrival of the contrast medium, its concentration can, with the help of Equations [B I] and [B3], be found from the enhancement factor, if the native T1 is known. The overall effect of the influx of contrast medium in practical concentrations is an increase in signal intensity because of T1 shortening. This relation is illustrated in Figure B1 . As expected, the enhancement factor is roughly proportional to concentration. At much higher concentrations, T2* shortening will become dominant and the enhancement will saturate. The figure shows, in addition, that for a given concentration, the enhancement factor is larger when the native T1 is longer. This last effect is due to the low signal strength in the precontrast images in regions with a long T1.
APPENDIX C
Phannacokinetic Model
The behavior of Gd-DTPA after its injection as a bolus into the human body is described as an exchange of Gd-DTPA between the compartments shown in Figure  C1 . After its introduction, the contrast medium will distribute rapidly in the plasma within the early distribution volume V, (38) .This volume roughly corresponds to that of the plasma in the vascular volume and is loosely referred to as "vascular space" in the remainder of this paper. The concentration in this compartment then drops off gradually because of diffusion into the leakage space of the body with volume V,. This model is similar to what is used in pharmacy to describe the distribution of drugs Figure C1 . Three-compartment model, used for pharmacokinetic modeling of the concentration of Gd-DTPA as a function of time.
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macokinetic model." For the purpose of analysis, this leakage space is thought of as divided into two spatially separate compartments, one of which, the voxel leakage space (volume VJ, is located in the voxel under consideration. The compartments exchange Gd-DTPA with transfer coefficients
Clearing from the vascular compartment via the kidney takes place as well and has a transfer coelficient klo.
The continuity equations that describe the exchange of matter between these compartments for a situation of passive concentration driven transport can be expressed as equations for the concentrations C,:
The transfer coefficients k, have the dimension t' and are formally described as the mean permeability surface area product per unit volume of Compartment i. Tofts et a1 (20) introduced for these coefficients the term "permeability," which convention we will follow. The third term in the first of these equations can be neglected because of the very small value of the ratio VJV,. When a dose D is injected at t = 0, C, is assumed to step up immediately to its initial value D/V,. Equation
[C 11 can then be solved. In Figure C2 , curves a and b, the obtained solutions for C, and C, are shown graphically for a typical set of parameters. As can be seen, C, has an initial value 1 and a n approximately exponential decrease. C3 starts at zero and shows washin first. After its peak concentration has been reached, the washout is at a rate that closely follows that of C,. Within a voxel, vascular space as well as leakage space will always be present and each will occupy a fraction of the total voxel volume. These fractions will be called fi and f,. The average concentration of Gd-DTPA in the voxel, C,, is the weighted sum of the concentrations in each volume fraction:
The MR signal is assumed to be a function of C,. This is true when there is fast exchange of spins between the compartments. Fast between cellular and extracellular space is expected (40) . It is reasonable as well to assume its existence between the capillaries and the vascular space The modeled behavior of C, is shown in Figure C2 (solid curves) for some values off,. The step of C, at t = 0 is proportional tof,; its increase then continues, starting at a slope Jd -k3,, which reflects the washin into the voxel leakage space, until the peak concentration is reached. As shown in the figure, the peak in C, is reached earlier than that in C,, especially for large .f,.
The output parameters of the model govern the shape of the concentration-time curves. These parameters are f,,f,, and ks1. Together with T1, and the actual MRI scan parameters, they describe the shape of the enhancementtime curve as well.
In our use of the model, a number of parameter values were assumed from the literature. These values and their assumed precision for the in vitro situation in the patient are listed in Table C 1. For the relaxivities r, and r, * of Gd-DTPA, we have used literature values observed by Tofts et a1 (42) in gradientecho experiments in gels at 1.5 T. The parameters \TI, V,, bl, and k,,, governing the decay of the plasma concentration of Gd-DTPA after bolus injection are based on experimental observations in plasma samples obtained from volunteers. These experiments of Weinmann (39) show a biexponential decay of the plasma concentration. The resulting values of the transfer coefficients follow from a mathematical reformulation.
APPENDIX D
Errors in the Parameters Obtained from the Pharmacokinetic Model
The errors in the derived parameters are the result of application of the fitting procedure to imperfect input data. Therefore, a n estimate of the errors in the input parameters has to be given first. Such estimates are discussed below and summarized in column 2 of Table D 1. An estimate of the resulting output errors can be obtained by observing the propagation of input errors in the fitting procedure for representative sets of input data (20) . We have applied this manner of error estimation in five actual input data sets in which the size of the enhancing regions ranged from 10 to 40 pixels and from 11 to 44 -sec-I. The input parameters were varied individually over their error range and the ranges of the resulting output errors are shown in Table D1 , columns 3 through 5. The estimated total error per parameter is obtained by quadratic addition of the error terms and is given at the bottom row of these columns.
The following input errors were considered: Error in the experimental values of T1. Experimental assessment of the accuracy of determination of T1 with our method (dual flip angle TI-FFE) was obtained with help of a phantom with calibrated values of T1 (43). In the range of T1 values of 200 to 1,000 msec, the phantom data were shown to be accurate within 5%. The clinical situation is less favorable. T1 decay may not be monoexponential and, in the large field of view used, the transmit coil may not be sufficiently homogeneous. A visual impression of the accuracy of T1 over the transverse breast images is given in Figure  lc , a parameter image of T1. T1 of the fat is constant over most of the field of view and much better than the signal in the unprocessed images l a and b. Nevertheless, the T1 values obtained will be approximate only. Their accuracy is expected to be only approximately 15%. 0 Movement of the patient between the dynamic scans was corrected by in-plane shifting of the images. After reregistration, the remaining in-plane error of movement was estimated to be less than .3 pixels. The movement perpendicular to the imaging plane is estimated to be less than 2 111111. The error in the data from patient movement was considered negligible and is not shown. Movement of the patient (presumably mainly respiratory motion) during each dynamic scan was cause of a slight ghost, visible for instance in the background of Figure la . The intensity of the ghost was a few percent of the scale maximum. For error analysis, it was assumed to behave as random noise. Image noise in the MRI data from the dynamic scans. The range of the thermal noise per pixel was observed to be smaller than 1% (2/.655 times the SD in a ghostfree background image region, compared with the scale maximum). Ghost and thermal noise together were estimated to have a range of 2% of the scale maximum. Intravoxel inhomogeneity was not observed directly. For small enhancing regions, partial volume effects during the dynamic scans can become an important reason for intravoxel inhomogeneity, which then may degrade the meaning of the parameter estimates. The restriction that was imposed for the minimum size of the enhancing region (eight pixels) reduces this influence of partial volume effects. The error caused by intravoxel inhomogeneity was estimated by increasing the voxel size in the test data sets with a factor of 2 and repeating the analysis. The value for pharmacokinetic input parameters V,, rl, rz*, V,, bl, and k,, were assumed to be accurate within 20% with the exception of r2*, which is likely to be less accurate (441, so we assumed 50% accuracy for that parameter.
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The range of transport times tt of the contrast medium from the place of injection to the breast was estimated from the data of Kruger (25) to be 15 ? 10 seconds. These data show, in addition, that the front edge of the bolus is not a step function but has a rise time of approximately 6 seconds. The influence of this finite rise time on the analysis was neglected in comparison with the temporal resolution of the dynamic scan (30 seconds).
